5/20/25 18:01 | 5/16/25 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | P.m | 175 | 0.4992 | 0 | 350 | 91 | 734 | D | | | | | | | | | | | | | | |
9/11/24 17:47 | 9/9/24 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | P.m | 395 | 2.82 | 0 | 140 | 57 | 384 | D | | | | | | | | | | | | | | |
1/31/24 18:29 | 1/29/24 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | P.m | 387 | 3.87 | 0 | 100 | 69 | 244 | D | | | | | | | | | | | | | | |
12/12/22 20:00 | 12/8/22 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | P | 116 | 2.10 | 0 | 55 | 62 | 144 | D | | | | | | | | | | | | | | |
4/18/16 17:24 | 4/14/16 | ATNM | Actinium Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | NY | D | | P.dm | 6 | 2.02 | 1 | 3 | New | 3 | D | -83 | -38 | -10 | -4 | -1 | -1 | -1 | -1 | 0 | 3 | -10 | -15 | -43 | |
12/17/15 09:36 | 12/15/15 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | NY | DO | CEO | P | 58 | 3.05 | 0 | 19 | 6 | 339 | D | | | | | | | | | | | | | | |
12/16/15 16:25 | 12/14/15 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | NY | DO | CEO | P | 0 | 2.97 | 0 | 0 | 0 | 320 | D | | | | | | | | | | | | | | |